177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors
Clinical trial NCT06632873 · RECRUITING
Trial details
- NCT number
- NCT06632873
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-01-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.